Dow, S&P Both Jump to Record Highs - Will Congress Decision Impact Marijuana Index?


Follow this company

Companies Mentioned

OTC:BB:CBIS / PK:MNTR / OTC:BB:GBLX
06/06/2014 [ACCESSWIRE]

Carlsbad, CA / June 6, 2014 / To recap an exciting Thursday trading session -- the Dow rose 0.6% closing at a record high of 16,836.11 with an intraday high of 16,845.81; while the S&P 500 also gained 0.6%, posting an all-time high of 1940.46 and intraday high of 1941.74.  The Nasdaq composite index gained 1.1% with an added 44.58 points closing at 4296.23, well below the all time high of 5,048.62.

The Marijuana Index remained flat, closing Thursday at 3.23 -- leaving many investors to wonder how a recent congressional decision might eventually impact the sector.

U.S. House of Representatives Peels the Proverbial Band-Aid 

Make no mistake, this is big news for marijuana (and possibly marijuana equities in the long-term).   "Congress is officially pulling out of the war on medical marijuana patients and providers," said Dan Riffle, director of federal policies for the Marijuana Policy Project.

Last week, a seemingly overlooked announcement emerged from Washington DC:  the U.S. House of Representatives voted for an end to all DEA medical cannabis raids.  Technically speaking, the U.S. House of Representatives voted on an amendment to a bill for the Department of Justice, which controls the DEA and related resources.  Once introduced as the Hinchey-Rohrabacher amendment, the bill is now cosponsored by Congressmen Sam Farr (D-CA) and Dana Rohrabacher (R-CA).  

Still requiring a Democratic U.S. Senate ratification, approval from two regulatory committees, and President Obama's signature -- some feel the potential change comes too little, too late.  Others believe the legal logic puts the federal government in a position which "toes the line of constitutionality" wherein the DOJ becomes the arbiter of state legislation, something which goes against the "ideals and the common practice of more than 200 years of American federalism."

In any event, cannabis is firmly at the forefront of every branch of government and has just scratched the surface of financial markets -- a natural progression for the nascent industry.  Widely considered an issue championed by democrats, it should be noted that Congressman Dana Rohrabacher (a republican) has been at the forefront of the marijuana movement for years.  While many industry insiders are skeptical as to what this the passage means, a spirit of cautious optimism should prevail.  Never before has cannabis seen more favor on the federal level, period.

According to a Wikipedia page for the Hinchey-Rohrabacher amendment, the amendment in various forms has been voted on by the House a full seven times.  Never garnering more than 165 affirmative "ayes" previously, it passed last week with a staggering 219 votes in favor.  These results, combined with recent advances toward definitive banking regulations and emerging capital markets, could go a long way toward restoring investor sentiment in the sector.

Get FREE Periodic Updates from the Official Marijuana Index Newsletter 

Cannabis Science Reports Strongest Financial Position in Company History

Widely regarded as one of the "founders" of cannabis equities -- Cannabis Science (OTCQB:  CBIS) announced positive news this week which helped shares gain more than 10% on Thursday, closing at $0.117 per share on strong volume of more than 15 million shares.  The company is engaged in research and development of cannabinoid-based therapies.

Cannabis Science's CFO Robert Kane announced, "Cannabis Science is in the strongest financial position in the Company's history. With a positive cash position after the successful capital raise earlier this year, the Company has the ability to conduct basic science research and to begin new cannabis-drug development programs. In fact, this has begun and our development team is analyzing proprietary data right now."

Learn More about Cannabis Science by Visiting the Issuer Website

FREE Sign-Up for Marijuana Index Newsletter

Mentor Capital Announces First Quarter Revenues

Per a series of press releases this week, Mentor Capital (OTC Pink:  MNTR) issued updates as the company deploys its intended acquisition and integration strategy of cannabis companies. 

The most recent release states "on an unaudited basis the company, as of March 31, 2014, reports that it holds $1,574,783 in cash, with consolidated assets of $14,158,030 and has common equity of $4,598,826. The quarterly revenues were $534,889 ($2,139,556 annualized rate) and it operated at a net loss of $56,171 or approximately a loss of one-half cent per share across 10,181,062 average diluted shares outstanding during the first quarter."

The company also announced this week the funding of Bhang Financial, which intends to provide credit card processing for the cannabis industry, as well as $100K in start-up capital for Nevada Cannabis Ventures -- a subsidiary which intends to deploy capital in Nevada-based marijuana businesses. 

Mentor also detailed team additions including a California DOJ Senior Legal Analyst & CPA Director of Audit Services.  Any move to bolster financial accountability in light of recent regulatory actions should be well-received, and this could be the first step toward Mentor Capital becoming a fully-reporting (and audited) company.

Learn More About Mentor Capital by Visiting the Issuer Website

FREE Sign-Up for The Marijuana Index Newsletter 

GrowBLOX Sciences CEO Issues Shareholder Update; Raises $5,000,000 via Private Placement

GrowBLOX Sciences, Inc. (OTCQB: GBLX), a biotechnology and research company whose mission is to grow and provide high-grade pharmaceutical cannabis to the medical marijuana industry and perfect the cultivation process, issued a series of updates this week which were summarized today in a letter to shareholders.

Per the release, the first GrowBLOX cultivation chamber has come off of the production line -- the CEO Craig Ellins also said "we (GrowBLOX) are not growing from seeds, clippings or clones. Our technology will allow us to grow from tissue, something that, to our knowledge, no other medical marijuana company is doing. We are in the process of hiring a vast assortment of scientists, who collectively hold various Ph.D.'s and patent portfolios."  The company also announced progress toward its Nevada medical marijuana license applications, as well as the formation of a subsidiary in Puerto Rico which is intended to position GrowBLOX in a new jurisdiction currently weighing medical legalization.  The company website details more about their plans and product.

Perhaps most notably, GrowBLOX appears to have sufficient capital to progress their business plan.  On Monday the company detailed a $5 million raise completed via private placement.  Shares were sold to accredited and institutional investors, and proceeds will be used to support GrowBLOX Sciences' continued growth, as well as for general corporate purposes.  As of June 2nd, 2014 the company reports that they have just shy of 21,500,000 common shares outstanding.  MJX Marijuana Index was paid for advertising services by a third-party for featuring GrowBLOX Sciences on both our website and in certain written materials such as this article.

FREE Sign-Up for Marijuana Index Newsletter

About The Marijuana Index / MJX Marijuana Index

Network partners of marijuana media leaders Cannabis Financial Network (http://www.cannabisfn.com/), The Marijuana Index was founded in Q1 2013 and represents the first and only registered equity tracking index for marijuana stocks, cannabis stocks, and hemp stocks – providing investors and listed companies with dynamic market data and streaming content.  The Marijuana Index provides marijuana investors and interested observers with a medium for research, charts, and a centralized news source on an emerging and turbulent marijuana industry.

Readers are urged to visit http://www.marijuanaindex.org/ for up-to-date information and to sign up for updates.  Follow The Marijuana Index on Twitter @MarijuanaIndex. 

Companies or websites wishing to advertise on the index shouldcontactadvertisers@marijuanaindex.org – advertising packages are now available.

DISCLAIMER 

The Marijuana Index (MJX Marijuana Index, the "index") is a data aggregation service and does not provide promotional efforts, other than text sponsorship or visual advertisements, unless otherwise noted.  The Marijuana Index does not offer investment advice.  Nothing listed on MarijuanaIndex.org or within this release is an offer to buy or sell securities.  Readers are cautioned against using information obtained from The Marijuana Index as a basis for any investment decision.  The Marijuana Index makes no warranties or representations as to the accuracy of posted or streamed information on MarijuanaIndex.org or from companies on the site or within the index news feeds.  The Marijuana Index was paid $20,000 cash by a third party to provide visual sponsorship and newsletter placement for OTCQB:  GBLX for approximately one month of services.  The Marijuana Index reserves the right to buy or sell shares in listed or mentioned companies without notice.  The Marijuana Index has been registered with leading financial content provider Quotemedia with the ticker ^MMJ since Q1 2013 (the word "registered" is not meant to imply registration with the SEC).  The Marijuana Index makes no expressed or implied warranties or representations regarding changes to the index weighting or inclusion / removal of constituents, tier system, current and future features of the website, or any company or sponsor (either product, public issuer, or newsletter) listed or shown on MarijuanaIndex.org or their respective performance.  

For more information on the index disclaimer, visit http://www.marijuanaindex.org/ and click on "About" and "Disclaimer."

INCLUSION IN THE MARIJUANA INDEX OR PAID SITE SPONSORSHIP BY ISSUERS / THIRD-PARTY SHAREHOLDERS DOES NOT IMPLY THAT DUE DILIGENCE OR EVALUATION ON ANY LEVEL HAS BEEN CONDUCTED ON LISTED OR SPONSOR COMPANIES.
COMMENTS

Leave a comment...
 * 

Your Name
 *